Generation Bio Co
GBIO4.545USD
+0.335+7.96%
Horário de mercado （ET）Cotações atrasadas em 15 min
304.55MValor de mercado
PerdaP/L TTM
Mais detalhes de Generation Bio Co Empresa
Generation Bio Co. is a biotechnology company. The Company is innovating non-viral genetic medicines to provide durable, redosable treatments for hundreds of millions of patients living with rare and prevalent diseases. The Company is developing two distinct and complementary platforms: a potent, highly selective cell-targeted lipid nanoparticle (ctLNP) delivery system and a novel immune-quiet DNA (iqDNA) cargo produced by a scalable capsid-free manufacturing process that uses proprietary cell-free rapid enzymatic synthesis (RES). The Company is advancing a portfolio of programs guided by the potent and highly selective delivery of messenger ribonucleic acid (mRNA) and/or iqDNA using its ctLNP delivery system to target T cells, hematopoietic stem cells (HSCs), and hepatocytes, and intend to expand to additional tissues and cell types. Its work in T cells focuses on in vivo reprogramming of this cell type to treat cancer and autoimmune diseases.
Informações da empresa
Código da empresaGBIO
Nome da EmpresaGeneration Bio Co
Data de listagemJun 12, 2020
CEODr. Cameron Geoffrey (Geoff) Mcdonough, M.D.
Número de funcionários115
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 12
Endereço301 Binney Street
CidadeCAMBRIDGE
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal02142
Telefone18575295908
Sitehttps://generationbio.com/
Código da empresaGBIO
Data de listagemJun 12, 2020
CEODr. Cameron Geoffrey (Geoff) Mcdonough, M.D.
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Cameron Geoffrey (Geoff) Mcdonough, M.D.
Dr. Cameron Geoffrey (Geoff) Mcdonough, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
185.48K
+0.20%
Dr. Anthony G. Quinn, M.D., Ph.D.
Dr. Anthony G. Quinn, M.D., Ph.D.
Independent Director
Independent Director
37.21K
--
Mr. Gustav A. Christensen
Mr. Gustav A. Christensen
Independent Director
Independent Director
13.14K
--
Dr. Phillip Samayoa, Ph.D.
Dr. Phillip Samayoa, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
12.93K
+0.63%
Ms. Yalonda Howze, J.D.
Ms. Yalonda Howze, J.D.
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
6.70K
+3.67%
Dr. Catherine Stehman-Breen, M.D.
Dr. Catherine Stehman-Breen, M.D.
Independent Director
Independent Director
4.75K
--
Ms. Dannielle Appelhans
Ms. Dannielle Appelhans
Independent Director
Independent Director
2.00K
+150.00%
Mr. Kevin John Conway
Mr. Kevin John Conway
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
1.83K
+2.35%
Mr. Ronald Harold Wilfred (Ron) Cooper
Mr. Ronald Harold Wilfred (Ron) Cooper
Independent Director
Independent Director
950.00
--
Mr. Jason Rhodes
Mr. Jason Rhodes
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Cameron Geoffrey (Geoff) Mcdonough, M.D.
Dr. Cameron Geoffrey (Geoff) Mcdonough, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
185.48K
+0.20%
Dr. Anthony G. Quinn, M.D., Ph.D.
Dr. Anthony G. Quinn, M.D., Ph.D.
Independent Director
Independent Director
37.21K
--
Mr. Gustav A. Christensen
Mr. Gustav A. Christensen
Independent Director
Independent Director
13.14K
--
Dr. Phillip Samayoa, Ph.D.
Dr. Phillip Samayoa, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
12.93K
+0.63%
Ms. Yalonda Howze, J.D.
Ms. Yalonda Howze, J.D.
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
6.70K
+3.67%
Dr. Catherine Stehman-Breen, M.D.
Dr. Catherine Stehman-Breen, M.D.
Independent Director
Independent Director
4.75K
--
Detalhamento da receita
FY2024
FY2023
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
United States
19.89M
0.00%
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: sáb, 17 de mai
Atualizado em: sáb, 17 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
T. Rowe Price Associates, Inc.
13.25%
Atlas Venture
12.35%
Modernatx Inc
8.74%
Fidelity Management & Research Company LLC
7.09%
BlackRock Institutional Trust Company, N.A.
4.64%
Other
53.93%
Investidores
Investidores
Proporção
T. Rowe Price Associates, Inc.
13.25%
Atlas Venture
12.35%
Modernatx Inc
8.74%
Fidelity Management & Research Company LLC
7.09%
BlackRock Institutional Trust Company, N.A.
4.64%
Other
53.93%
Tipos de investidores
Investidores
Proporção
Investment Advisor
38.32%
Venture Capital
12.43%
Investment Advisor/Hedge Fund
9.30%
Corporation
8.74%
Hedge Fund
6.59%
Individual Investor
5.64%
Research Firm
5.05%
Family Office
0.13%
Bank and Trust
0.09%
Other
13.72%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
204
5.77M
86.15%
-1.71M
2025Q1
216
58.42M
87.25%
-16.87M
2024Q4
239
64.26M
96.22%
-10.38M
2024Q3
252
65.74M
98.51%
-9.46M
2024Q2
257
65.96M
99.11%
-9.63M
2024Q1
256
65.28M
99.25%
-2.56M
2023Q4
262
62.66M
95.79%
-3.14M
2023Q3
260
66.58M
101.93%
-550.54K
2023Q2
272
66.62M
102.34%
-297.13K
2023Q1
283
66.66M
111.77%
+650.55K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
T. Rowe Price Associates, Inc.
8.88M
13.25%
-217.22K
-2.39%
Mar 31, 2025
Atlas Venture
8.28M
12.35%
--
--
Mar 31, 2025
Modernatx Inc
5.86M
8.74%
--
--
Apr 07, 2025
Fidelity Management & Research Company LLC
4.75M
7.09%
+126.37K
+2.73%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.11M
4.64%
-49.92K
-1.58%
Mar 31, 2025
Invus Public Equities Advisors, LLC
2.97M
4.43%
-13.81K
-0.46%
Mar 31, 2025
The Vanguard Group, Inc.
2.62M
3.91%
-22.29K
-0.84%
Mar 31, 2025
Baker Bros. Advisors LP
1.94M
2.9%
--
--
Mar 31, 2025
Renaissance Technologies LLC
1.88M
2.81%
+917.71K
+95.30%
Mar 31, 2025
McDonough (Cameron Geoffrey)
1.85M
2.76%
+15.31K
+0.83%
Apr 15, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
Proshares Ultra Russell 2000
0%
Global X Russell 2000 Covered Call ETF
0%
iShares Micro-Cap ETF
0%
iShares Russell 2000 ETF
0%
iShares Biotechnology ETF
0%
Avantis US Small Cap Equity ETF
0%
Fidelity Blue Chip Growth ETF
0%
Avantis US Equity ETF
0%
ProShares Ultra Nasdaq Biotechnology
0%
Invesco RAFI US 1500 Small-Mid ETF
0%
Ver Mais
Proshares Ultra Russell 2000
Proporção0%
Global X Russell 2000 Covered Call ETF
Proporção0%
iShares Micro-Cap ETF
Proporção0%
iShares Russell 2000 ETF
Proporção0%
iShares Biotechnology ETF
Proporção0%
Avantis US Small Cap Equity ETF
Proporção0%
Fidelity Blue Chip Growth ETF
Proporção0%
Avantis US Equity ETF
Proporção0%
ProShares Ultra Nasdaq Biotechnology
Proporção0%
Invesco RAFI US 1500 Small-Mid ETF
Proporção0%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
